首页 > 最新文献

DEN open最新文献

英文 中文
Pancreatitis Following Biliary Endoscopic Retrograde Cholangiopancreatography for Common Bile Duct Stones in Japan: A Multicenter Prospective Cohort Study 日本一项多中心前瞻性队列研究:胆内镜逆行胆管造影治疗胆总管结石后胰腺炎。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-23 DOI: 10.1002/deo2.70265
Toru Maruo, Koichi Fujita, Shujiro Yazumi, Hiroko Nebiki, Kazuya Matsumoto, Mamoru Takenaka, Toshiharu Ueki, Takashi Kawamura, Hirofumi Kawamoto

Objectives

Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is an adverse event of ERCP-related procedures. The present study aimed to evaluate the incidence of PEP in patients with an intact papilla who underwent ERCP for common bile duct stones and identify risk factors and preventive measures for PEP.

Methods

Between April 2017 and March 2018, ERCP-related procedures were performed in 16,032 patients with an intact papilla at 36 institutions affiliated with the Bilio-pancreatic Study Group of West Japan. Of these, 3739 were prospectively enrolled to investigate adverse events of ERCP-related procedures targeting the biliary tract; the present study included 2106 patients with common bile duct stones.

Results

PEP occurred in 132 patients (6.3%), and its severity was graded as mild (n = 104), moderate (n = 17), and severe (n = 11). Multivariable analysis identified the followin significant risk factors for PEP: age <50 years, female sex, wire-guided biliary cannulation, pancreatic guidewire-assisted biliary cannulation, biliary cannulation attempt duration ≥10 min, and total procedure time ≥60 min. Only pancreatic stenting was a preventive factor for PEP.

Conclusions

To prevent PEP, it is necessary to avoid guidewire insertion into the pancreatic duct, prolonged biliary cannulation attempts, and long ERCP procedure time, regardless of biliary cannulation with or without guidewire assistance. When a guidewire is inserted into the pancreatic duct in patients at high risk of PEP, pancreatic stenting should be considered.

目的:内镜逆行胰胆管造影(ERCP)后胰腺炎(PEP)是ERCP相关手术的不良事件。本研究旨在评估因胆总管结石而行ERCP的乳头完整患者PEP的发生率,并确定PEP的危险因素和预防措施。方法:2017年4月至2018年3月期间,在西日本胆道-胰腺研究组所属的36家机构对16032例完整乳头患者进行了ercp相关手术。其中,3739人被纳入前瞻性研究,以调查针对胆道的ercp相关手术的不良事件;本研究纳入了2106例胆总管结石患者。结果:PEP发生132例(6.3%),严重程度分为轻度(n = 104)、中度(n = 17)、重度(n = 11)。结论:为了预防PEP,有必要避免导丝插入胰管,延长胆道插管尝试时间,延长ERCP手术时间,无论是否有导丝辅助胆道插管。在PEP高危患者胰管内插入导丝时,应考虑胰支架植入术。
{"title":"Pancreatitis Following Biliary Endoscopic Retrograde Cholangiopancreatography for Common Bile Duct Stones in Japan: A Multicenter Prospective Cohort Study","authors":"Toru Maruo,&nbsp;Koichi Fujita,&nbsp;Shujiro Yazumi,&nbsp;Hiroko Nebiki,&nbsp;Kazuya Matsumoto,&nbsp;Mamoru Takenaka,&nbsp;Toshiharu Ueki,&nbsp;Takashi Kawamura,&nbsp;Hirofumi Kawamoto","doi":"10.1002/deo2.70265","DOIUrl":"10.1002/deo2.70265","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is an adverse event of ERCP-related procedures. The present study aimed to evaluate the incidence of PEP in patients with an intact papilla who underwent ERCP for common bile duct stones and identify risk factors and preventive measures for PEP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Between April 2017 and March 2018, ERCP-related procedures were performed in 16,032 patients with an intact papilla at 36 institutions affiliated with the Bilio-pancreatic Study Group of West Japan. Of these, 3739 were prospectively enrolled to investigate adverse events of ERCP-related procedures targeting the biliary tract; the present study included 2106 patients with common bile duct stones.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>PEP occurred in 132 patients (6.3%), and its severity was graded as mild (<i>n</i> = 104), moderate (<i>n</i> = 17), and severe (<i>n</i> = 11). Multivariable analysis identified the followin significant risk factors for PEP: age &lt;50 years, female sex, wire-guided biliary cannulation, pancreatic guidewire-assisted biliary cannulation, biliary cannulation attempt duration ≥10 min, and total procedure time ≥60 min. Only pancreatic stenting was a preventive factor for PEP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>To prevent PEP, it is necessary to avoid guidewire insertion into the pancreatic duct, prolonged biliary cannulation attempts, and long ERCP procedure time, regardless of biliary cannulation with or without guidewire assistance. When a guidewire is inserted into the pancreatic duct in patients at high risk of PEP, pancreatic stenting should be considered.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12723312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145829363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adalimumab-responsive Monogenic Inflammatory Bowel Disease With Pseudopolyposis Characteristic of TGFBR2 Variant in Loeys-Dietz Syndrome 阿达木单抗反应性单基因炎性肠病伴假息肉病在Loeys-Dietz综合征中的TGFBR2变异特征
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-19 DOI: 10.1002/deo2.70266
Tomomitsu Sado, Satoshi Ukai, Shingo Kurasawa, Yosuke Kono, Norio Hasuda, Mai Iwaya, Takaya Nakane, Tomomi Yamaguchi, Tomoki Kosho, Yoshiko Nakayama

Loeys-Dietz syndrome (LDS) is an autosomal dominant connective tissue disorder caused by pathogenic variants in TGFBR1 or TGFBR2. It is characterized by vascular fragility, skeletal abnormalities, and predisposition to allergic and inflammatory conditions, including monogenic inflammatory bowel disease (IBD). We report a pediatric case of IBD with a TGFBR2 variant, presenting active colonic inflammation and pseudopolyposis, treated with adalimumab.

At age 7, the patient presented with abdominal pain and bloody stools. Upon referral, colonoscopy demonstrated mucosal fragility, prominent pseudopolyposis, and an anal fissure, accompanied by a skin tag was identified. Genetic analysis revealed a heterozygous TGFBR2 c.1583G>A (p.Arg528His) variant and heterozygous MEFV E148Q and P369S-R408Q variants. Colchicine treatment for suspected familial Mediterranean fever-associated enteritis had a limited effect. Adalimumab treatment was initiated, leading to endoscopic improvement, with resolution of anemia and inflammatory markers in the blood test. This report presents the clinical course and endoscopic features potentially specific to the TGFBR2 c.1583G>A variant, with reference to previously published cases.

Loeys-Dietz综合征(LDS)是一种常染色体显性结缔组织疾病,由TGFBR1或TGFBR2的致病变异引起。它的特点是血管脆弱,骨骼异常,易患过敏和炎症,包括单基因炎症性肠病(IBD)。我们报告一例伴有TGFBR2变异的IBD患儿,表现为活动性结肠炎症和假性息肉病,接受阿达木单抗治疗。7岁时,患者出现腹痛和便血。转诊后,结肠镜检查显示粘膜脆弱,假性息肉突出,肛裂伴皮赘。遗传分析显示TGFBR2 c.1583G> a (p.a g528his)杂合变异和MEFV E148Q和P369S-R408Q杂合变异。秋水仙碱治疗疑似家族性地中海热相关肠炎的效果有限。开始阿达木单抗治疗,导致内窥镜改善,血液检查中贫血和炎症标志物得到解决。本报告介绍了TGFBR2 c.1583G>A变异的临床病程和内窥镜特征,并参考了先前发表的病例。
{"title":"Adalimumab-responsive Monogenic Inflammatory Bowel Disease With Pseudopolyposis Characteristic of TGFBR2 Variant in Loeys-Dietz Syndrome","authors":"Tomomitsu Sado,&nbsp;Satoshi Ukai,&nbsp;Shingo Kurasawa,&nbsp;Yosuke Kono,&nbsp;Norio Hasuda,&nbsp;Mai Iwaya,&nbsp;Takaya Nakane,&nbsp;Tomomi Yamaguchi,&nbsp;Tomoki Kosho,&nbsp;Yoshiko Nakayama","doi":"10.1002/deo2.70266","DOIUrl":"10.1002/deo2.70266","url":null,"abstract":"<p>Loeys-Dietz syndrome (LDS) is an autosomal dominant connective tissue disorder caused by pathogenic variants in <i>TGFBR1</i> or <i>TGFBR2</i>. It is characterized by vascular fragility, skeletal abnormalities, and predisposition to allergic and inflammatory conditions, including monogenic inflammatory bowel disease (IBD). We report a pediatric case of IBD with a <i>TGFBR2</i> variant, presenting active colonic inflammation and pseudopolyposis, treated with adalimumab.</p><p>At age 7, the patient presented with abdominal pain and bloody stools. Upon referral, colonoscopy demonstrated mucosal fragility, prominent pseudopolyposis, and an anal fissure, accompanied by a skin tag was identified. Genetic analysis revealed a heterozygous <i>TGFBR2</i> c.1583G&gt;A (p.Arg528His) variant and heterozygous <i>MEFV</i> E148Q and P369S-R408Q variants. Colchicine treatment for suspected familial Mediterranean fever-associated enteritis had a limited effect. Adalimumab treatment was initiated, leading to endoscopic improvement, with resolution of anemia and inflammatory markers in the blood test. This report presents the clinical course and endoscopic features potentially specific to the <i>TGFBR2</i> c.1583G&gt;A variant, with reference to previously published cases.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12716436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of the Stent-in-Stent Technique as a Rescue Method for Removing Embedded Metallic Biliary Stents 支架内支架技术作为一种取出嵌埋金属胆道支架的抢救方法的疗效。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-17 DOI: 10.1002/deo2.70246
Yasuhiro Komori, Susumu Hijioka, Yoshikuni Nagashio, Shota Harai, Daiki Yamashige, Kazunori Onuma, Keita Fujisaki, Daiki Agarie, Kohei Okamoto, Shin Yagi, Soma Fukuda, Masaru Kuwada, Joshua Josef Torres, Keijiro Ueda, Nao Fujimori, Yutaka Saito, Yoshihiro Ogawa, Takuji Okusaka

Objectives

Self-expandable metal stents (SEMS) may become embedded because of tissue hyperplasia or tumor ingrowth, making their removal challenging. The stent-in-stent (SIS) method, which involves placing another SEMS inside to compress the tissue and aid removal, is a known rescue approach for stent removal. However, its efficacy across anatomical routes, optimal timing of removal, and predictors of difficult stent removal remain unclear.

Methods

We retrospectively reviewed 17 patients treated between April 2018 and May 2025. Embedded stents were placed via the transpapillary route, endoscopic ultrasonography-guided hepaticogastrostomy (EUS-HGS), or choledochojejunal anastomosis. Technical success rates and adverse events were evaluated.

Results

The overall technical success rate was 76.5%, with rates of 80.0%, 100%, and 33.3% for the transpapillary route, EUS-HGS, and choledochojejunal anastomosis, respectively. Three of the four failures occurred when removal was attempted within 4 weeks of the second stent placement. Stent removal was successful in 100% of the hyperplasia cases but in 60% of the ingrowth cases. Cholecystitis occurred in one case after the second stent placement.

Conclusions

The SIS method is feasible for the transpapillary route and EUS-HGS but may show limited efficacy in choledochojejunal anastomosis. Stent removal 4 weeks after the second stent placement improves the success rate. The SIS method may be less effective in cases of malignant ingrowth.

目的:自膨胀金属支架(SEMS)可能因组织增生或肿瘤向内生长而嵌入,使其移除具有挑战性。支架内支架(SIS)方法,包括在内部放置另一个SEMS来压缩组织并帮助移除,是一种已知的支架移除的救援方法。然而,其在解剖途径、最佳取出时间和难以取出支架的预测因素方面的有效性仍不清楚。方法:回顾性分析2018年4月至2025年5月期间接受治疗的17例患者。通过经乳头、超声内镜引导下肝胃吻合术(EUS-HGS)或胆肠吻合术放置嵌入支架。评估技术成功率和不良事件。结果:总技术成功率为76.5%,其中经乳头吻合术80.0%,EUS-HGS吻合术100%,胆总管空肠吻合术33.3%。4例失败中有3例发生在第二次支架放置后4周内。支架移除在100%的增生病例中成功,但在60%的长入病例中成功。第二次支架置入后发生胆囊炎1例。结论:SIS法适用于经乳头途径和EUS-HGS,但在胆总管空肠吻合术中效果有限。第二次置入支架后4周取出支架可提高成功率。SIS方法在恶性肿瘤长入的情况下可能效果较差。
{"title":"Efficacy of the Stent-in-Stent Technique as a Rescue Method for Removing Embedded Metallic Biliary Stents","authors":"Yasuhiro Komori,&nbsp;Susumu Hijioka,&nbsp;Yoshikuni Nagashio,&nbsp;Shota Harai,&nbsp;Daiki Yamashige,&nbsp;Kazunori Onuma,&nbsp;Keita Fujisaki,&nbsp;Daiki Agarie,&nbsp;Kohei Okamoto,&nbsp;Shin Yagi,&nbsp;Soma Fukuda,&nbsp;Masaru Kuwada,&nbsp;Joshua Josef Torres,&nbsp;Keijiro Ueda,&nbsp;Nao Fujimori,&nbsp;Yutaka Saito,&nbsp;Yoshihiro Ogawa,&nbsp;Takuji Okusaka","doi":"10.1002/deo2.70246","DOIUrl":"10.1002/deo2.70246","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Self-expandable metal stents (SEMS) may become embedded because of tissue hyperplasia or tumor ingrowth, making their removal challenging. The stent-in-stent (SIS) method, which involves placing another SEMS inside to compress the tissue and aid removal, is a known rescue approach for stent removal. However, its efficacy across anatomical routes, optimal timing of removal, and predictors of difficult stent removal remain unclear.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively reviewed 17 patients treated between April 2018 and May 2025. Embedded stents were placed via the transpapillary route, endoscopic ultrasonography-guided hepaticogastrostomy (EUS-HGS), or choledochojejunal anastomosis. Technical success rates and adverse events were evaluated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The overall technical success rate was 76.5%, with rates of 80.0%, 100%, and 33.3% for the transpapillary route, EUS-HGS, and choledochojejunal anastomosis, respectively. Three of the four failures occurred when removal was attempted within 4 weeks of the second stent placement. Stent removal was successful in 100% of the hyperplasia cases but in 60% of the ingrowth cases. Cholecystitis occurred in one case after the second stent placement.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The SIS method is feasible for the transpapillary route and EUS-HGS but may show limited efficacy in choledochojejunal anastomosis. Stent removal 4 weeks after the second stent placement improves the success rate. The SIS method may be less effective in cases of malignant ingrowth.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145784018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Conventional Ideal Button Versus New Ideal Button ZERO for Percutaneous Endoscopic Gastrostomy Catheter Replacement 经皮内镜下胃造口导管置换术中传统理想按钮与新型零理想按钮的比较分析
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-10 DOI: 10.1002/deo2.70261
Kazuya Miyaguchi, Hisashi Matsumoto, Yuki Shiko, Yoshikazu Tsuzuki, Maiko Osawa, Rie Shiomi, Keiji Yamamoto, Yohei Kawasaki, Hiroyuki Imaeda

Objectives

Regular exchange of percutaneous endoscopic gastrostomy (PEG) catheters is crucial for preventing infection and maintaining function; however, procedure-related complications and patient discomfort remain major concerns. This study aimed to compare the clinical outcomes of the conventional Ideal Button with those of the newly developed Ideal Button ZERO (Olympus Corporation).

Methods

In this retrospective observational study, we included 82 PEG catheter exchange procedures, performed in 42 patients. Because some patients underwent repeated exchanges, analyses were conducted on a per-procedure basis. Patients were categorized into two groups: Group N (conventional to conventional Ideal Button exchange, n = 33) and Group Z (exchange to Ideal Button ZERO, n = 49). Group Z was further subdivided into subgroups Z1 (conventional to ZERO, n = 29) and Z2 (ZERO to ZERO, n = 20). The outcomes included the procedure time, complication rates (procedure-related and postoperative), and family satisfaction score.

Results

Procedure-related complications occurred only in Group Z (0/33 vs. 6/49; 0% vs. 12.2%) (p = 0.076). Postoperative complication rates were similar between the groups (Group N 6/33 [18.2%] vs. Group Z 9/49 [18.4%], p = 1.00). However, procedure time was shorter in Group Z than in Group N (8.24 ± 5.21 vs. 6.14 ± 4.28 min, p = 0.049). Family satisfaction scores showed no significant differences between the groups (Group N: 3.88 ± 1.52 vs. Group Z: 3.94 ± 1.39, p = 0.854).

Conclusions

The new Ideal Button ZERO showed a reduced procedure time; however, it revealed a trend toward higher procedure-related complications without clear superiority over conventional devices. Improved proficiency with the new device may reduce complication rates, warranting further investigation as its adoption increases.

Trial Registration

2025-047

目的定期更换经皮内镜胃造口术(PEG)导管对预防感染和维持功能至关重要;然而,手术相关并发症和患者不适仍然是主要问题。本研究旨在比较传统理想按钮与新开发的理想按钮ZERO (Olympus Corporation)的临床结果。方法在这项回顾性观察性研究中,我们纳入了42例患者的82例PEG导管置换手术。由于一些患者进行了反复的交换,分析是在每次手术的基础上进行的。患者分为两组:N组(常规到常规理想按钮交换,N = 33)和Z组(理想按钮零交换,N = 49)。Z组进一步分为Z1组(常规至零组,n = 29)和Z2组(零至零组,n = 20)。结果包括手术时间、并发症发生率(手术相关和术后)和家庭满意度评分。结果仅Z组出现手术相关并发症(0/33 vs. 6/49; 0% vs. 12.2%) (p = 0.076)。两组术后并发症发生率相似(N 6/33组[18.2%]vs Z 9/49组[18.4%],p = 1.00)。但Z组手术时间短于N组(8.24±5.21∶6.14±4.28 min, p = 0.049)。两组患者家庭满意度评分差异无统计学意义(N组:3.88±1.52,Z组:3.94±1.39,p = 0.854)。结论新型ZERO理想按钮缩短了手术时间;然而,它显示了一种更高的手术相关并发症的趋势,与传统装置相比没有明显的优势。提高对新设备的熟练程度可以降低并发症发生率,随着其采用的增加,需要进一步的研究。试验注册2025-047
{"title":"Comparative Analysis of Conventional Ideal Button Versus New Ideal Button ZERO for Percutaneous Endoscopic Gastrostomy Catheter Replacement","authors":"Kazuya Miyaguchi,&nbsp;Hisashi Matsumoto,&nbsp;Yuki Shiko,&nbsp;Yoshikazu Tsuzuki,&nbsp;Maiko Osawa,&nbsp;Rie Shiomi,&nbsp;Keiji Yamamoto,&nbsp;Yohei Kawasaki,&nbsp;Hiroyuki Imaeda","doi":"10.1002/deo2.70261","DOIUrl":"https://doi.org/10.1002/deo2.70261","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Regular exchange of percutaneous endoscopic gastrostomy (PEG) catheters is crucial for preventing infection and maintaining function; however, procedure-related complications and patient discomfort remain major concerns. This study aimed to compare the clinical outcomes of the conventional Ideal Button with those of the newly developed Ideal Button ZERO (Olympus Corporation).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this retrospective observational study, we included 82 PEG catheter exchange procedures, performed in 42 patients. Because some patients underwent repeated exchanges, analyses were conducted on a per-procedure basis. Patients were categorized into two groups: Group N (conventional to conventional Ideal Button exchange, <i>n</i> = 33) and Group Z (exchange to Ideal Button ZERO, <i>n</i> = 49). Group Z was further subdivided into subgroups Z1 (conventional to ZERO, <i>n</i> = 29) and Z2 (ZERO to ZERO, <i>n</i> = 20). The outcomes included the procedure time, complication rates (procedure-related and postoperative), and family satisfaction score.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Procedure-related complications occurred only in Group Z (0/33 vs. 6/49; 0% vs. 12.2%) (<i>p</i> = 0.076). Postoperative complication rates were similar between the groups (Group N 6/33 [18.2%] vs. Group Z 9/49 [18.4%], <i>p</i> = 1.00). However, procedure time was shorter in Group Z than in Group N (8.24 ± 5.21 vs. 6.14 ± 4.28 min, <i>p</i> = 0.049). Family satisfaction scores showed no significant differences between the groups (Group N: 3.88 ± 1.52 vs. Group Z: 3.94 ± 1.39, <i>p</i> = 0.854).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The new Ideal Button ZERO showed a reduced procedure time; however, it revealed a trend toward higher procedure-related complications without clear superiority over conventional devices. Improved proficiency with the new device may reduce complication rates, warranting further investigation as its adoption increases.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Trial Registration</h3>\u0000 \u0000 <p>2025-047</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70261","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145739692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced Visualization of the Distal Myotomy Endpoint during Peroral Endoscopic Myotomy Using Indocyanine Green With Infrared Imaging 利用吲哚菁绿红外成像增强经口内窥镜下肌切开术中远端肌切开术终点的可视化
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-10 DOI: 10.1002/deo2.70250
Yuichiro Ikebuchi, Takuki Sakaguchi, Moe Eizawa, Tsuyoshi Mikamo, Kazuhiro Takemoto, Yuki Fujii, Ryohei Ogihara, Yu Kamitani, Mirai Edano, Hidehito Kinoshita, Hiroki Kurumi, Takashi Hasegawa, Koichiro Kawaguchi, Kazuo Yashima, Hajime Isomoto

Background

Peroral endoscopic myotomy (POEM) is an effective treatment for achalasia; however, accurately identifying the distal extent of myotomy remains a technical challenge. Indocyanine green with infrared imaging (ICG-IRI) may facilitate the intraoperative visualization of the esophagogastric junction.

Methods

We evaluated 39 patients who underwent POEM using ICG-IRI. The primary outcome was the success rate of ICG-IRI, defined as a clear endoscopic visualization of fluorescence at the distal myotomy endpoint. The secondary outcomes included technical success, changes in integrated relaxation pressure, and Eckardt scores before and after treatment.

Results

The technical success rate was 100%, and ICG-IRI was successful in 94.9% of the cases (37/39). The median integrated relaxation pressure decreased from 26.9 to 10.8 mmHg, and the median Eckardt score improved from 5.0 to 1.0 (both p < 0.01). No adverse events were attributed to the ICG-IRI.

Conclusions

The ICG-IRI method is a reliable visual aid for identifying distal myotomy endpoints during POEM. This technique may enhance the procedural accuracy and improve clinical outcomes.

经口内窥镜下肌切开术(POEM)是治疗贲门失弛缓症的有效方法;然而,准确地确定远端肌切开术的范围仍然是一个技术挑战。吲哚菁绿红外成像(ICG-IRI)可以促进术中食管胃交界处的可视化。方法应用ICG-IRI对39例行POEM的患者进行评价。主要结果是ICG-IRI的成功率,定义为在远端肌切开术终点清晰的内镜下荧光可视化。次要结果包括技术成功、综合松弛压力的变化和治疗前后的Eckardt评分。结果技术成功率100%,ICG-IRI成功率94.9%(37/39)。中位综合松弛压从26.9下降到10.8 mmHg,中位Eckardt评分从5.0提高到1.0 (p < 0.01)。ICG-IRI无不良事件发生。结论在POEM术中,ICG-IRI法是一种可靠的视觉辅助工具,可用于识别远端肌切开术终点。这项技术可以提高手术的准确性和改善临床结果。
{"title":"Enhanced Visualization of the Distal Myotomy Endpoint during Peroral Endoscopic Myotomy Using Indocyanine Green With Infrared Imaging","authors":"Yuichiro Ikebuchi,&nbsp;Takuki Sakaguchi,&nbsp;Moe Eizawa,&nbsp;Tsuyoshi Mikamo,&nbsp;Kazuhiro Takemoto,&nbsp;Yuki Fujii,&nbsp;Ryohei Ogihara,&nbsp;Yu Kamitani,&nbsp;Mirai Edano,&nbsp;Hidehito Kinoshita,&nbsp;Hiroki Kurumi,&nbsp;Takashi Hasegawa,&nbsp;Koichiro Kawaguchi,&nbsp;Kazuo Yashima,&nbsp;Hajime Isomoto","doi":"10.1002/deo2.70250","DOIUrl":"https://doi.org/10.1002/deo2.70250","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Peroral endoscopic myotomy (POEM) is an effective treatment for achalasia; however, accurately identifying the distal extent of myotomy remains a technical challenge. Indocyanine green with infrared imaging (ICG-IRI) may facilitate the intraoperative visualization of the esophagogastric junction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We evaluated 39 patients who underwent POEM using ICG-IRI. The primary outcome was the success rate of ICG-IRI, defined as a clear endoscopic visualization of fluorescence at the distal myotomy endpoint. The secondary outcomes included technical success, changes in integrated relaxation pressure, and Eckardt scores before and after treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The technical success rate was 100%, and ICG-IRI was successful in 94.9% of the cases (37/39). The median integrated relaxation pressure decreased from 26.9 to 10.8 mmHg, and the median Eckardt score improved from 5.0 to 1.0 (both <i>p</i> &lt; 0.01). No adverse events were attributed to the ICG-IRI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The ICG-IRI method is a reliable visual aid for identifying distal myotomy endpoints during POEM. This technique may enhance the procedural accuracy and improve clinical outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70250","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145739691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining the Treatment Landscape in Gastroparesis: A Clinical Review of Gastric Peroral Endoscopic Myotomy Outcomes and Therapeutic Integration 重新定义胃轻瘫的治疗前景:经口胃内窥镜下肌切开术的疗效和治疗整合的临床回顾。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-09 DOI: 10.1002/deo2.70260
Kobina Essilfie-Quaye, Carson Creamer, Mohammad Abuassi, Harsimran Kalsi, Neeka Akhavan, Tony Brar, Yaseen Perbtani

Gastroparesis is a chronic gastric motility disorder marked by delayed gastric emptying in the absence of mechanical obstruction. For patients with symptoms refractory to medical and dietary therapy, Gastric Peroral Endoscopic Myotomy (G-POEM) has emerged as a minimally invasive, pylorus-targeted intervention that directly addresses pyloric dysfunction.

Technical success rates consistently exceed 95%, reflecting procedural standardization and a favorable learning curve. Short-term symptom improvement is reported in up to 80% of patients and is often accompanied by enhanced gastric emptying and quality of life (QOL). Long-term outcomes show sustained clinical success of 50%–77.5% at 3–4 years, influenced by disease etiology and neuromuscular progression. Endoluminal functional lumen imaging probe, a functional imaging tool that measures pyloric distensibility, has shown promise in identifying optimal candidates and assessing procedural efficacy, though standardized predictive thresholds are still lacking.

Overall, G-POEM has become a leading pylorus-directed therapy for refractory gastroparesis. Comparative data suggest that G-POEM offers superior clinical efficacy and durability relative to botulinum toxin injection and gastric electrical stimulation, with fewer complications than surgical pyloroplasty.

This review integrates the current clinical evidence supporting G-POEM, with a focus on patient selection, procedural outcomes, QOL, and durability of response. It also examines comparative data with alternative therapies and addresses ongoing areas of controversy, including procedural technique, repeat intervention, and the predictive value of prior pyloric-directed therapies. G-POEM represents a safe and effective treatment modality for appropriately selected patients and continues to shape the landscape of gastroparesis management.

胃轻瘫是一种慢性胃运动障碍,在没有机械阻塞的情况下,以胃排空延迟为特征。对于药物和饮食治疗难治性症状的患者,胃经口内窥镜肌切开术(G-POEM)已成为一种微创,直接解决幽门功能障碍的幽门靶向干预措施。技术成功率始终超过95%,反映了程序标准化和良好的学习曲线。据报道,高达80%的患者短期症状改善,通常伴有胃排空和生活质量(QOL)的改善。长期结果显示,受疾病病因和神经肌肉进展的影响,3-4年的持续临床成功率为50%-77.5%。腔内功能性管腔成像探针是一种测量幽门扩张的功能性成像工具,虽然仍然缺乏标准化的预测阈值,但它在确定最佳候选者和评估手术疗效方面显示出了希望。总体而言,G-POEM已成为治疗难治性胃轻瘫的主要幽门疗法。对比数据表明,G-POEM相对于肉毒杆菌毒素注射和胃电刺激具有更好的临床疗效和持久性,并发症少于手术幽门成形术。本综述整合了目前支持G-POEM的临床证据,重点关注患者选择、手术结果、生活质量和反应持久性。它还检查了与替代疗法的比较数据,并解决了正在进行的争议领域,包括程序技术,重复干预和先前幽门定向治疗的预测价值。G-POEM代表了一种安全有效的治疗方式,适用于适当选择的患者,并继续塑造胃轻瘫治疗的前景。
{"title":"Redefining the Treatment Landscape in Gastroparesis: A Clinical Review of Gastric Peroral Endoscopic Myotomy Outcomes and Therapeutic Integration","authors":"Kobina Essilfie-Quaye,&nbsp;Carson Creamer,&nbsp;Mohammad Abuassi,&nbsp;Harsimran Kalsi,&nbsp;Neeka Akhavan,&nbsp;Tony Brar,&nbsp;Yaseen Perbtani","doi":"10.1002/deo2.70260","DOIUrl":"10.1002/deo2.70260","url":null,"abstract":"<p>Gastroparesis is a chronic gastric motility disorder marked by delayed gastric emptying in the absence of mechanical obstruction. For patients with symptoms refractory to medical and dietary therapy, Gastric Peroral Endoscopic Myotomy (G-POEM) has emerged as a minimally invasive, pylorus-targeted intervention that directly addresses pyloric dysfunction.</p><p>Technical success rates consistently exceed 95%, reflecting procedural standardization and a favorable learning curve. Short-term symptom improvement is reported in up to 80% of patients and is often accompanied by enhanced gastric emptying and quality of life (QOL). Long-term outcomes show sustained clinical success of 50%–77.5% at 3–4 years, influenced by disease etiology and neuromuscular progression. Endoluminal functional lumen imaging probe, a functional imaging tool that measures pyloric distensibility, has shown promise in identifying optimal candidates and assessing procedural efficacy, though standardized predictive thresholds are still lacking.</p><p>Overall, G-POEM has become a leading pylorus-directed therapy for refractory gastroparesis. Comparative data suggest that G-POEM offers superior clinical efficacy and durability relative to botulinum toxin injection and gastric electrical stimulation, with fewer complications than surgical pyloroplasty.</p><p>This review integrates the current clinical evidence supporting G-POEM, with a focus on patient selection, procedural outcomes, QOL, and durability of response. It also examines comparative data with alternative therapies and addresses ongoing areas of controversy, including procedural technique, repeat intervention, and the predictive value of prior pyloric-directed therapies. G-POEM represents a safe and effective treatment modality for appropriately selected patients and continues to shape the landscape of gastroparesis management.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preclinical Evaluation of the Safety of the Dedicated Gel for Gel Immersion Endoscopy With Gastrointestinal Perforation and Peritoneal Leakage 专用凝胶用于胃肠道穿孔和腹膜渗漏凝胶浸泡内镜安全性的临床前评价。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-08 DOI: 10.1002/deo2.70258
Atsushi Ohata, Ryo Kawahara, Yuji Hiraki, Hikaru Nakata, Shinya Kaneda, Tomonori Yano

Objectives

Gel immersion endoscopic mucosal resection or endoscopic submucosal dissection has been developed as an alternative to saline immersion therapeutic endoscopy. However, in cases of gastrointestinal perforation, gel may leak from the lumen into the peritoneal cavity, and the safety of such events remains unclarified. This study aimed to evaluate the safety of the dedicated gel (Viscoclear, VC) in the event of perforation and peritoneal leakage.

Methods

A perforation model was created to compare the colonic burst pressure after VC or saline injection. Acute toxicity was assessed by intraperitoneal VC administration in rats at a maximum dose of 20 mL/kg. Escherichia coli was cultured for 24 h in VC or saline, and bacterial growth was evaluated. Cytotoxicity (colony formation of V79 cells), sensitization (guinea pig maximization test), and intracutaneous reactivity (local irritation in rabbits) were also examined.

Results

The burst pressure was significantly higher for VC injection than for saline. There were no abnormalities indicative of toxicity observed in the general condition or at necropsy after VC administration, and the hematological and biochemical parameters were within normal limits. VC did not promote bacterial growth compared with saline. VC was not cytotoxic and did not cause skin sensitization. Intradermal reactivity tests showed that VC caused negligible irritation that was judged “acceptable”.

Conclusions

These results suggest that VC is less likely to leak than saline and that, even in the event of a minor leakage into the peritoneal cavity, VC has no acute systemic toxicity and acceptable biocompatibility.

目的:凝胶浸泡内镜粘膜切除或内镜粘膜下剥离已发展成为替代盐水浸泡治疗性内镜。然而,在胃肠道穿孔的情况下,凝胶可能从管腔渗漏到腹膜腔,这种事件的安全性尚不清楚。本研究旨在评估专用凝胶(Viscoclear, VC)在穿孔和腹膜渗漏情况下的安全性。方法:建立穿孔模型,比较VC与生理盐水注射后结肠破裂压力。以最大剂量为20 mL/kg的VC腹腔给药大鼠进行急性毒性评价。将大肠杆菌在VC或生理盐水中培养24 h,观察细菌生长情况。细胞毒性(V79细胞集落形成)、致敏性(豚鼠最大化试验)和皮内反应性(家兔局部刺激)也被检测。结果:VC注射组的破裂压力明显高于生理盐水组。VC给药后一般情况及尸检未见毒性异常,血液学及生化指标均在正常范围内。与生理盐水相比,VC对细菌生长没有促进作用。VC没有细胞毒性,也不会引起皮肤致敏。皮内反应性试验表明,VC引起的刺激可以忽略不计,被认为是“可接受的”。结论:这些结果表明VC比生理盐水更不容易泄漏,即使在少量渗漏进入腹腔的情况下,VC也没有急性全身毒性和可接受的生物相容性。
{"title":"Preclinical Evaluation of the Safety of the Dedicated Gel for Gel Immersion Endoscopy With Gastrointestinal Perforation and Peritoneal Leakage","authors":"Atsushi Ohata,&nbsp;Ryo Kawahara,&nbsp;Yuji Hiraki,&nbsp;Hikaru Nakata,&nbsp;Shinya Kaneda,&nbsp;Tomonori Yano","doi":"10.1002/deo2.70258","DOIUrl":"10.1002/deo2.70258","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Gel immersion endoscopic mucosal resection or endoscopic submucosal dissection has been developed as an alternative to saline immersion therapeutic endoscopy. However, in cases of gastrointestinal perforation, gel may leak from the lumen into the peritoneal cavity, and the safety of such events remains unclarified. This study aimed to evaluate the safety of the dedicated gel (Viscoclear, VC) in the event of perforation and peritoneal leakage.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A perforation model was created to compare the colonic burst pressure after VC or saline injection. Acute toxicity was assessed by intraperitoneal VC administration in rats at a maximum dose of 20 mL/kg. <i>Escherichia coli</i> was cultured for 24 h in VC or saline, and bacterial growth was evaluated. Cytotoxicity (colony formation of V79 cells), sensitization (guinea pig maximization test), and intracutaneous reactivity (local irritation in rabbits) were also examined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The burst pressure was significantly higher for VC injection than for saline. There were no abnormalities indicative of toxicity observed in the general condition or at necropsy after VC administration, and the hematological and biochemical parameters were within normal limits. VC did not promote bacterial growth compared with saline. VC was not cytotoxic and did not cause skin sensitization. Intradermal reactivity tests showed that VC caused negligible irritation that was judged “acceptable”.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These results suggest that VC is less likely to leak than saline and that, even in the event of a minor leakage into the peritoneal cavity, VC has no acute systemic toxicity and acceptable biocompatibility.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12684772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Ultrasound-Guided Bile Duct Drainage Enhances Oncological Systemic Therapy Initiation and Capability in Patients With Non-Resectable Malignant Distal Bile Duct Obstructions Compared to Percutaneous Transhepatic Biliary Drainage 与经皮经肝胆管引流相比,超声内镜引导胆管引流可提高不可切除的恶性远端胆管阻塞患者的肿瘤系统治疗启动和能力。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-08 DOI: 10.1002/deo2.70262
Thomas Roland Heiduk, Andre Sasse, Volker Ellenrieder, Lukas Hiebel, Richard Friedemann Knoop, Golo Petzold, Ahmad Amanzada

Introduction

Endoscopic retrograde cholangiopancreaticography (ERCP) is the gold standard for bile duct drainage in non-resectable malignant distal bile duct obstruction with jaundice in pancreaticobiliary and duodenal neoplasia. Failed ERCP is either followed by endoscopic ultrasound-guided biliary drainage (EUS-BD) or percutaneous transhepatic biliary drainage (PTBD) as an alternative procedure. This study compares the ability to initiate and continue oncological systemic therapy in patients treated with EUS-BD versus PTBD.

Methods

In this retrospective, comparative cohort study, 96 consecutive patients were analyzed. Oncological, demographic, and laboratory parameters were examined, focusing on the capability to initiate chemotherapy and the time interval from intervention to chemotherapy initiation.

Results

The EUS-BD group showed a greater reduction in serum bilirubin levels before chemotherapy (2.2 mg/dL vs. 3.9 mg/dL, p = 0.04) and had a significantly greater degree of change in bilirubin levels after 10 days (70% vs. 30%, p = 0.01). More patients in the EUS-BD cohort received chemotherapy (69% vs. 48%, p = 0.04), and the interval between intervention and chemotherapy initiation was shorter (10 vs. 17 days, p = 0.02). The type and number of chemotherapies administered did not differ significantly between the groups (p = 0.43; p = 0.50; p = 0.12). Reinterventions and complication rates were significantly lower in the EUS-BD cohort (6% vs. 60%, p = 0.004 and 56% vs. 92%, p = 0.004).

Conclusion

EUS-BD appears superior to PTBD in facilitating the initiation of oncological systemic therapy, with fewer complications and a shorter time to treatment initiation. Further multicenter studies are needed to confirm these findings.

内镜逆行胆管造影(ERCP)是胰胆十二指肠肿瘤中不可切除的恶性远端胆管梗阻伴黄疸的胆管引流的金标准。ERCP失败后,内镜超声引导胆道引流(EUS-BD)或经皮经肝胆道引流(PTBD)作为替代手术。这项研究比较了EUS-BD与PTBD患者启动和继续肿瘤系统治疗的能力。方法:对96例连续患者进行回顾性、比较队列研究。检查肿瘤、人口统计学和实验室参数,重点关注开始化疗的能力和从干预到化疗开始的时间间隔。结果:EUS-BD组化疗前血清胆红素水平下降幅度更大(2.2 mg/dL vs. 3.9 mg/dL, p = 0.04), 10天后胆红素水平变化幅度更大(70% vs. 30%, p = 0.01)。EUS-BD队列中接受化疗的患者较多(69%对48%,p = 0.04),干预与化疗开始的间隔时间较短(10天对17天,p = 0.02)。化疗的类型和次数在两组间无显著差异(p = 0.43; p = 0.50; p = 0.12)。EUS-BD组的再干预和并发症发生率明显较低(6%对60%,p = 0.004, 56%对92%,p = 0.004)。结论:EUS-BD在促进肿瘤系统治疗启动方面优于PTBD,并发症少,启动治疗时间短。需要进一步的多中心研究来证实这些发现。
{"title":"Endoscopic Ultrasound-Guided Bile Duct Drainage Enhances Oncological Systemic Therapy Initiation and Capability in Patients With Non-Resectable Malignant Distal Bile Duct Obstructions Compared to Percutaneous Transhepatic Biliary Drainage","authors":"Thomas Roland Heiduk,&nbsp;Andre Sasse,&nbsp;Volker Ellenrieder,&nbsp;Lukas Hiebel,&nbsp;Richard Friedemann Knoop,&nbsp;Golo Petzold,&nbsp;Ahmad Amanzada","doi":"10.1002/deo2.70262","DOIUrl":"10.1002/deo2.70262","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Endoscopic retrograde cholangiopancreaticography (ERCP) is the gold standard for bile duct drainage in non-resectable malignant distal bile duct obstruction with jaundice in pancreaticobiliary and duodenal neoplasia. Failed ERCP is either followed by endoscopic ultrasound-guided biliary drainage (EUS-BD) or percutaneous transhepatic biliary drainage (PTBD) as an alternative procedure. This study compares the ability to initiate and continue oncological systemic therapy in patients treated with EUS-BD versus PTBD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this retrospective, comparative cohort study, 96 consecutive patients were analyzed. Oncological, demographic, and laboratory parameters were examined, focusing on the capability to initiate chemotherapy and the time interval from intervention to chemotherapy initiation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The EUS-BD group showed a greater reduction in serum bilirubin levels before chemotherapy (2.2 mg/dL vs. 3.9 mg/dL, <i>p</i> = 0.04) and had a significantly greater degree of change in bilirubin levels after 10 days (70% vs. 30%, <i>p</i> = 0.01). More patients in the EUS-BD cohort received chemotherapy (69% vs. 48%, <i>p</i> = 0.04), and the interval between intervention and chemotherapy initiation was shorter (10 vs. 17 days, <i>p</i> = 0.02). The type and number of chemotherapies administered did not differ significantly between the groups (<i>p</i> = 0.43; <i>p</i> = 0.50; <i>p</i> = 0.12). Reinterventions and complication rates were significantly lower in the EUS-BD cohort (6% vs. 60%, <i>p</i> = 0.004 and 56% vs. 92%, <i>p</i> = 0.004).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>EUS-BD appears superior to PTBD in facilitating the initiation of oncological systemic therapy, with fewer complications and a shorter time to treatment initiation. Further multicenter studies are needed to confirm these findings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Gastric Metastasis of Renal Cell Carcinoma Resected by Endoscopic Submucosal Dissection After Endoscopic Follow-up of Morphological Changes 肾细胞癌胃转移灶经内镜下粘膜下剥离术切除1例。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-01 DOI: 10.1002/deo2.70257
Yuichi Fukami, Nagako Nishihira, Kazuki Kawakami, Yuka Hayakawa, Yuki Matsui, Midori Wakiya, Masayoshi Fukuda, Hiromichi Shimizu, Kazuo Ohtsuka, Ryuichi Okamoto

A 62-year-old man underwent partial nephrectomy for right renal cell carcinoma (RCC). Four years later, esophagogastroduodenoscopy revealed gastric mucosal redness with a smooth surface. Two more years later, the red lesion showed a morphological change to a reddish elevation, which prompted a biopsy. Histopathological examination led to the diagnosis of gastric metastasis of RCC. As the tumor resided within the submucosa and no other organ metastasis was found after nephrectomy by that time, endoscopic submucosal dissection (ESD) was performed and successfully resected. No evidence of local recurrence was noted for 7 years after ESD. Topical resection, such as ESD, can be considered an option to treat the gastric metastasis of RCC for which there are no established treatment guidelines. In this case report, we aimed to investigate a rare case of gastric metastasis of RCC, which was monitored endoscopically, showing morphological changes over several years, and was successfully resected by ESD.

一位62岁男性因右肾细胞癌(RCC)接受部分肾切除术。四年后,食管胃十二指肠镜检查显示胃粘膜发红,表面光滑。两年后,红色病变显示形态改变为红色升高,这促使进行活组织检查。组织病理学检查诊断为肾细胞癌胃转移。由于肿瘤位于粘膜下层,且当时行肾切除术后未发现其他器官转移,故行内镜下粘膜下层剥离术(ESD)并成功切除。ESD术后7年未见局部复发。局部切除,如ESD,可以被认为是治疗RCC胃转移的一种选择,目前尚无既定的治疗指南。在这个病例报告中,我们的目的是研究一个罕见的RCC胃转移病例,该病例在内镜下监测,表现出几年的形态学变化,并成功地通过ESD切除。
{"title":"A Case of Gastric Metastasis of Renal Cell Carcinoma Resected by Endoscopic Submucosal Dissection After Endoscopic Follow-up of Morphological Changes","authors":"Yuichi Fukami,&nbsp;Nagako Nishihira,&nbsp;Kazuki Kawakami,&nbsp;Yuka Hayakawa,&nbsp;Yuki Matsui,&nbsp;Midori Wakiya,&nbsp;Masayoshi Fukuda,&nbsp;Hiromichi Shimizu,&nbsp;Kazuo Ohtsuka,&nbsp;Ryuichi Okamoto","doi":"10.1002/deo2.70257","DOIUrl":"10.1002/deo2.70257","url":null,"abstract":"<p>A 62-year-old man underwent partial nephrectomy for right renal cell carcinoma (RCC). Four years later, esophagogastroduodenoscopy revealed gastric mucosal redness with a smooth surface. Two more years later, the red lesion showed a morphological change to a reddish elevation, which prompted a biopsy. Histopathological examination led to the diagnosis of gastric metastasis of RCC. As the tumor resided within the submucosa and no other organ metastasis was found after nephrectomy by that time, endoscopic submucosal dissection (ESD) was performed and successfully resected. No evidence of local recurrence was noted for 7 years after ESD. Topical resection, such as ESD, can be considered an option to treat the gastric metastasis of RCC for which there are no established treatment guidelines. In this case report, we aimed to investigate a rare case of gastric metastasis of RCC, which was monitored endoscopically, showing morphological changes over several years, and was successfully resected by ESD.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12669802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Non-intubated Behavioral Pain Scale Score During Replacement of Ideal Button ZERO and Non-ZERO Gastrostomy Tubes 理想扣零与非零胃造口管置换时非插管行为疼痛量表评分的比较
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-27 DOI: 10.1002/deo2.70254
Kazumi Shimamoto, Masanori Hongo, Naoki Dan, Naoko Mori, Yu Kobayashi, Hiromitsu Ban

Objective

Many patients report pain during bumper-type gastrostomy tube replacement. The Ideal Button ZERO (ZERO) is a 24-Fr bumper-type gastrostomy tube that was developed to eliminate such pain, but its efficacy has not yet been evaluated. We compared the pain during replacement of the ZERO and of other non-ZERO bumper-type gastrostomy tubes.

Methods

This retrospective cohort study included 180 patients who underwent gastrostomy tube replacement at our institution during 2023–2024. The primary outcome was the Non-intubated Behavioral Pain Scale (BPS-NI) score when the gastrostomy tubes were replaced. Scores were compared among ZERO, non-ZERO 20-Fr, and non-ZERO 24-Fr groups.

Results

Pain during gastrostomy tube removal was assessed in 80 (44.4%), 66 (36.7%), and 34 (18.9%) patients in the ZERO, non-ZERO 20-Fr, and non-ZERO 24-Fr groups, respectively. The median BPS-NI was significantly lower in the ZERO (3.0 [interquartile range [IQR]: 3.0–3.0]) than non-ZERO 20-Fr (6.0 [IQR: 4.0–8.0]) and non-ZERO 24-Fr (5.0 [IQR: 4.0–7.0]) groups. Pain during gastrostomy tube insertion was assessed as follows: the ZERO was replaced from a 24-Fr tube and a 20-Fr tube in 80 (44.4%) and 41 (22.8%) cases, respectively; a non-ZERO 20-Fr tube and a non-ZERO 24-Fr tube were inserted in 25 (13.9%) and 34 (18.9%) cases, respectively. The median BPS-NI score was significantly lower in the ZERO (replaced 24-Fr) group (3.0 [IQR: 3.0–3.3]) than in both the non-ZERO 20-Fr (5.0 [IQR: 3.0–6.0]) and non-ZERO 24-Fr (5.0 [IQR: 4.0–6.0]) groups.

Conclusions

Use of the ZERO reduces pain during gastrostomy tube replacement.

目的许多患者报告在缓冲器式胃造口管置换过程中疼痛。Ideal Button ZERO (ZERO)是一种24-Fr缓冲器式胃造口管,旨在消除这种疼痛,但其疗效尚未得到评估。我们比较了ZERO和其他非ZERO缓冲器型胃造口管更换时的疼痛。方法回顾性队列研究纳入了2018 - 2024年在我院行胃造口管置换术的180例患者。主要结果是更换胃造口管时的非插管行为疼痛量表(BPS-NI)评分。比较0组、非0 20-Fr组和非0 24-Fr组的评分。结果零组、非零组20-Fr组和非零组24-Fr组分别有80例(44.4%)、66例(36.7%)和34例(18.9%)患者在胃造口管拔除过程中出现疼痛。0组(3.0[四分位间距[IQR]: 3.0 - 3.0])的中位BPS-NI显著低于20-Fr组(6.0 [IQR: 4.0-8.0])和24-Fr组(5.0 [IQR: 4.0-7.0])。胃造口管插入疼痛评估如下:分别有80例(44.4%)和41例(22.8%)由24-Fr管和20-Fr管替换ZERO管;非zero 20-Fr插管25例(13.9%),非zero 24-Fr插管34例(18.9%)。0(替代24-Fr)组(3.0 [IQR: 3.0 - 3.3])的中位BPS-NI评分显著低于非0- fr (5.0 [IQR: 3.0 - 6.0])和非0- fr (5.0 [IQR: 4.0-6.0])组。结论ZERO可减轻胃造口管更换过程中的疼痛。
{"title":"Comparison of the Non-intubated Behavioral Pain Scale Score During Replacement of Ideal Button ZERO and Non-ZERO Gastrostomy Tubes","authors":"Kazumi Shimamoto,&nbsp;Masanori Hongo,&nbsp;Naoki Dan,&nbsp;Naoko Mori,&nbsp;Yu Kobayashi,&nbsp;Hiromitsu Ban","doi":"10.1002/deo2.70254","DOIUrl":"https://doi.org/10.1002/deo2.70254","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Many patients report pain during bumper-type gastrostomy tube replacement. The Ideal Button ZERO (ZERO) is a 24-Fr bumper-type gastrostomy tube that was developed to eliminate such pain, but its efficacy has not yet been evaluated. We compared the pain during replacement of the ZERO and of other non-ZERO bumper-type gastrostomy tubes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective cohort study included 180 patients who underwent gastrostomy tube replacement at our institution during 2023–2024. The primary outcome was the Non-intubated Behavioral Pain Scale (BPS-NI) score when the gastrostomy tubes were replaced. Scores were compared among ZERO, non-ZERO 20-Fr, and non-ZERO 24-Fr groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Pain during gastrostomy tube removal was assessed in 80 (44.4%), 66 (36.7%), and 34 (18.9%) patients in the ZERO, non-ZERO 20-Fr, and non-ZERO 24-Fr groups, respectively. The median BPS-NI was significantly lower in the ZERO (3.0 [interquartile range [IQR]: 3.0–3.0]) than non-ZERO 20-Fr (6.0 [IQR: 4.0–8.0]) and non-ZERO 24-Fr (5.0 [IQR: 4.0–7.0]) groups. Pain during gastrostomy tube insertion was assessed as follows: the ZERO was replaced from a 24-Fr tube and a 20-Fr tube in 80 (44.4%) and 41 (22.8%) cases, respectively; a non-ZERO 20-Fr tube and a non-ZERO 24-Fr tube were inserted in 25 (13.9%) and 34 (18.9%) cases, respectively. The median BPS-NI score was significantly lower in the ZERO (replaced 24-Fr) group (3.0 [IQR: 3.0–3.3]) than in both the non-ZERO 20-Fr (5.0 [IQR: 3.0–6.0]) and non-ZERO 24-Fr (5.0 [IQR: 4.0–6.0]) groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Use of the ZERO reduces pain during gastrostomy tube replacement.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"6 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70254","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145626416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
DEN open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1